XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.73

-0.2%

11:31 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (6796)	7/26/1998 12:52:00 AM
From: aknahow	Read Replies (1) of 17367

And like Biostock1 used to say, treatment begins at once even before the exact bateria is identified. "Treatment: Hospitalization is necessary to achieve treatment goals. Intravenous antibiotic therapy should be initiated as soon as the diagnosis is suspected. The therapy is not delayed while determining the causative organism. Sometimes more than one type of antibiotic is given while results of the blood cultures are pending. Antibiotics can then be changed when the culture results are available and the causative organism is known. The source of the infection should be identified if possible, which may mean further diagnostic testing. Sources such as infected intravenous lines or surgical drains can be removed, and sources such as abscesses can be surgically drained. Supportive therapy with oxygen and intravenous fluid and management of complications is important for a good outcome. "

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next